MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

In this study involving 2103 men with elevated PSA levels, the use of both MRI-targeted and 12-core systematic biopsies was more effective at detecting clinically significant prostate cancers than either biopsy method alone.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-03, Vol.382 (10), p.917-928
Hauptverfasser: Ahdoot, Michael, Wilbur, Andrew R, Reese, Sarah E, Lebastchi, Amir H, Mehralivand, Sherif, Gomella, Patrick T, Bloom, Jonathan, Gurram, Sandeep, Siddiqui, Minhaj, Pinsky, Paul, Parnes, Howard, Linehan, W. Marston, Merino, Maria, Choyke, Peter L, Shih, Joanna H, Turkbey, Baris, Wood, Bradford J, Pinto, Peter A
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Aged
Biopsy
Biopsy - methods
Cancer surgery
Cancer therapies
Clinical trials
Humans
Lesions
Magnetic Resonance Imaging
Male
Medical diagnosis
Middle Aged
Neoplasm Grading
Patients
Prostate - pathology
Prostate cancer
Prostate-Specific Antigen - blood
Prostatectomy
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Prostatic Neoplasms - surgery
Reclassification
Software
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study involving 2103 men with elevated PSA levels, the use of both MRI-targeted and 12-core systematic biopsies was more effective at detecting clinically significant prostate cancers than either biopsy method alone.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1910038